LV10839B - Remedy for prophylactics and treatment of lipoid and cholesterol metabolism upset, method for prophylactics and treatment thereof - Google Patents

Remedy for prophylactics and treatment of lipoid and cholesterol metabolism upset, method for prophylactics and treatment thereof Download PDF

Info

Publication number
LV10839B
LV10839B LVP-93-1238A LV931238A LV10839B LV 10839 B LV10839 B LV 10839B LV 931238 A LV931238 A LV 931238A LV 10839 B LV10839 B LV 10839B
Authority
LV
Latvia
Prior art keywords
galacturonic acid
treatment
prophylactics
hjih
acid derivative
Prior art date
Application number
LVP-93-1238A
Other languages
English (en)
Latvian (lv)
Other versions
LV10839A (lv
Inventor
Schaefer Hans-Ludwig
Schneider Werner
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of LV10839A publication Critical patent/LV10839A/xx
Publication of LV10839B publication Critical patent/LV10839B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
LVP-93-1238A 1990-04-06 1993-11-17 Remedy for prophylactics and treatment of lipoid and cholesterol metabolism upset, method for prophylactics and treatment thereof LV10839B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4011285A DE4011285A1 (de) 1990-04-06 1990-04-06 Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose
PCT/EP1991/000654 WO1991015214A1 (de) 1990-04-06 1991-04-06 Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose

Publications (2)

Publication Number Publication Date
LV10839A LV10839A (lv) 1995-10-20
LV10839B true LV10839B (en) 1996-04-20

Family

ID=6403968

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1238A LV10839B (en) 1990-04-06 1993-11-17 Remedy for prophylactics and treatment of lipoid and cholesterol metabolism upset, method for prophylactics and treatment thereof

Country Status (17)

Country Link
US (1) US5434141A (ja)
EP (1) EP0476113B1 (ja)
JP (1) JPH05500673A (ja)
KR (1) KR920700656A (ja)
AT (1) ATE135223T1 (ja)
AU (1) AU639097B2 (ja)
CA (1) CA2063588A1 (ja)
DE (2) DE4011285A1 (ja)
DK (1) DK0476113T3 (ja)
ES (1) ES2086538T3 (ja)
GR (1) GR3019866T3 (ja)
HU (1) HU218925B (ja)
LT (1) LT3543B (ja)
LV (1) LV10839B (ja)
RU (1) RU2108788C1 (ja)
UA (1) UA35566C2 (ja)
WO (1) WO1991015214A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6084067A (en) * 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
US6824779B1 (en) 1993-07-26 2004-11-30 Dana-Farber Cancer Institute, Inc. Methods for inhibiting the interaction of B7-2 with its natural ligand
JPH0948732A (ja) * 1995-08-04 1997-02-18 Pola Chem Ind Inc 活性酸素消去剤及びそれを含む組成物
US6929807B1 (en) 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
ATE218065T1 (de) * 1996-08-09 2002-06-15 Mannatech Inc Zusammensetzungen auf pflanzliicher kohlenhydratbasis als nahrungsergänzungsstoffe
US5942500A (en) * 1998-04-27 1999-08-24 Perry; Stephen C. Dietary composition to reduce dietary fats
US6462029B1 (en) * 1999-02-23 2002-10-08 Econugenics Compositions and methods for treating mammals with modified alginates and modified pectins
WO2008011216A2 (en) 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
WO2012138213A1 (en) * 2011-04-08 2012-10-11 N.V. Nutricia Reduction of vascular dysfunction with specific saccharides
EP2755480B1 (en) * 2011-09-16 2021-03-31 Galectin Therapeutics Inc. Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease
BR112014030534A2 (pt) 2012-06-06 2017-06-27 Galectin Therapeutics Inc composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2370961A (en) * 1941-11-15 1945-03-06 Rohm & Haas Preparation of alpha-d-galacturonic acid
DE2036605A1 (de) * 1970-07-23 1972-05-31 Mylaeus, Armin, 5970 Plettenberg Diätbrot und Verfahren zu seiner Herstellung
DE2521765B2 (de) * 1975-05-16 1979-01-18 Valentin Dr.Med. Koehler Verwendung von D-Glucuronsäure, dessen γ -Lacton, Galacturonsäure oder Mannuronsäure
US4122179A (en) * 1976-06-03 1978-10-24 Enrico Corvi Mora Acid addition salts of vincamine and apovincamine
JPS54119038A (en) * 1978-03-07 1979-09-14 Takeda Chemical Industries Ltd Digestion difficult polysaccaride containing food
FR2449452A1 (fr) * 1978-11-15 1980-09-19 Krauter Henri Nouveau medicament utile notamment comme diuretique et detoxicant, derive de l'acide galacturonique
JPS59206045A (ja) * 1983-05-11 1984-11-21 Asahi Chem Ind Co Ltd 低比重リポ蛋白質吸着材
DD271415A3 (de) * 1983-07-05 1989-09-06 Akad Wissenschaften Ddr Verfahren zur herstellung eines pektindiaetetikums
US4617276A (en) * 1985-01-23 1986-10-14 Agway Inc. Novel method for quantitating structural and non-structural carbohydrates in feedstuffs
US4615891A (en) * 1985-01-23 1986-10-07 Agway Inc. Method of formulating dairy cow rations based on carbohydrate regulation
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
DK81690D0 (da) * 1990-03-30 1990-03-30 Grindsted Prod As Pektinprodukt og fremgangsmaade til fremstilling deraf

Also Published As

Publication number Publication date
GR3019866T3 (en) 1996-08-31
UA35566C2 (uk) 2001-04-16
JPH05500673A (ja) 1993-02-12
AU639097B2 (en) 1993-07-15
RU2108788C1 (ru) 1998-04-20
EP0476113A1 (de) 1992-03-25
HU218925B (hu) 2000-12-28
ES2086538T3 (es) 1996-07-01
ATE135223T1 (de) 1996-03-15
CA2063588A1 (en) 1991-10-07
LV10839A (lv) 1995-10-20
US5434141A (en) 1995-07-18
DE4011285A1 (de) 1991-10-10
LTIP1534A (en) 1995-06-26
HUT61199A (en) 1992-12-28
DK0476113T3 (da) 1996-07-15
EP0476113B1 (de) 1996-03-13
KR920700656A (ko) 1992-08-10
WO1991015214A1 (de) 1991-10-17
DE59107536D1 (de) 1996-04-18
AU7664991A (en) 1991-10-30
HU913814D0 (en) 1992-04-28
LT3543B (en) 1995-11-27

Similar Documents

Publication Publication Date Title
LV10839B (en) Remedy for prophylactics and treatment of lipoid and cholesterol metabolism upset, method for prophylactics and treatment thereof
JP6656345B2 (ja) 治療指数の改善されたニトロキシル供与体
US2108765A (en) Preserving and disinfecting media
CA2614885C (en) Methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities
EP0996448B1 (en) Treatment and prevention of adhesions
JP2002502423A (ja) 進行性組織壊死、再灌流損傷、細菌トランスロケーションおよび成人呼吸窮迫症候群の予防方法
EP2061530B1 (en) Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
JP2011087931A (ja) 生体吸収性外科手術用組成物
JP2019513795A5 (ja)
US5922701A (en) Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
Davis et al. Attenuation of aortic aneurysms with stem cells from different genders
Servais et al. Functional mechanics of a pectin-based pleural sealant after lung injury
US10463610B2 (en) Composition comprising diacid derivatives and their use in the treatment of collagenic eye disorders
Schreinemacher et al. Collagen fleeces do not improve colonic anastomotic strength but increase bowel obstructions in an experimental rat model
EP0875246A1 (en) Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer
EP2968698B1 (en) Coating for drug release
Zahger et al. VCL, an antagonist of the platelet GP1b receptor, markedly inhibits platelet adhesion and intimal thickening after balloon injury in the rat
Kamitani et al. Prevention of retrosternal adhesion by novel biocompatible glue derived from food additives
WO1981000566A1 (en) N-(hydroxymethyl)-n-(1,3-dihydroxymethyl-2,5-dioxo-4-imidazolidinyl)-n'-(hydroxymethyl)urea,preservative compositions and use thereof
Galanopoulos et al. The effects of iloprost on colonic anastomotic healing in rats
Higo et al. Preoperative embolization for paraganglioma
RU94046058A (ru) Агент для лечения и профилактики катаракты, способ его получения, применение (+) - (2s, 3s)-3 (s)-3-метил-1-(3-метилбутилкарбомоил)бутилкарбамоил]-2-оксикарбоновой кислоты ее соли и ее этилового эфира для получения агента, способ лечения и профилактики катаракты, способ получения водного раствора
AU2012244256B2 (en) Novel drug delivery devices
CN112316134A (zh) Pd-1作为静脉移植物术后预防内膜增生的药物的应用
US20020010210A1 (en) Pharmaceutical preparation and method for treating cancer